Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.3 SEK | +3.72% | +6.00% | +22.00% |
Sales 2024 * | 104M 9.51M 761M | Sales 2025 * | 393M 35.94M 2.88B | Capitalization | 1.93B 177M 14.14B |
---|---|---|---|---|---|
Net income 2024 * | -151M -13.8M -1.1B | Net income 2025 * | -166M -15.17M -1.21B | EV / Sales 2024 * | 16 x |
Net cash position 2024 * | 274M 25.02M 2B | Net cash position 2025 * | 222M 20.28M 1.62B | EV / Sales 2025 * | 4.35 x |
P/E ratio 2024 * |
-12.8
x | P/E ratio 2025 * |
-7.74
x | Employees | 24 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 86.02% |
Latest transcript on Vicore Pharma Holding AB
1 day | +3.72% | ||
1 week | +6.00% | ||
Current month | +17.85% | ||
1 month | +15.33% | ||
3 months | +28.34% | ||
6 months | +30.47% | ||
Current year | +22.00% |
Managers | Title | Age | Since |
---|---|---|---|
Ahmed Mousa
CEO | Chief Executive Officer | 40 | 08/09/23 |
Hans Jeppsson
DFI | Director of Finance/CFO | - | 31/12/16 |
Elin Rosendahl
CTO | Chief Tech/Sci/R&D Officer | - | 15/11/20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 57 | 31/12/17 | |
Director/Board Member | 66 | 31/12/17 | |
Michael Buschle
BRD | Director/Board Member | 64 | 31/12/22 |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 17.3 | +3.72% | 92,932 |
25/04/24 | 16.68 | -2.91% | 149,676 |
24/04/24 | 17.18 | -1.49% | 96,148 |
23/04/24 | 17.44 | +2.95% | 160,468 |
22/04/24 | 16.94 | +3.80% | 107,729 |
Delayed Quote Nasdaq Stockholm, April 26, 2024 at 04:29 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.00% | 176M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- VICO Stock